The curcumin–EGCG combination inhibited angiogenesis in CM-induced tumor cells through suppression of the JAK/STAT3 pathway, and the inhibitory effects on tumor growth and angiogenesis were evidently greater in a xenograft mouse model than those observed after EGCG or curcumin monotreatment. This evidence concerns the gene STAT3 and neoplasm.